Immunotherapy research in head and neck cancer

0 Views

07/06/23

Immunotherapy in recurrent and metastatic head and neck cancers is now a part of standard care. Dana-Farber Cancer Institute researchers are now investigating using those immunotherapies earlier, before the head and neck cancer spreads or comes back.
Story published 2/26/2020